New dialysis fluid shows promise for kidney patients in Real-World test

NCT ID NCT06492031

Completed Disease control Sponsor: Vantive Health LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special dialysis fluid called icodextrin in 439 adults with chronic kidney failure who use peritoneal dialysis at home. The goal was to see if it works better than standard glucose solutions for overnight exchanges and to check for side effects. Researchers tracked how many patients had to switch to a different dialysis method or died. The study was observational, meaning patients got their usual care, and results will help doctors choose the best treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RENAL FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC RENAL FAILURE

Contacts and locations

Locations

Beijing Haidian Hospital

Beijing, 100000, China
Hangzhou Hospital Of Traditional Chinese Medicine

Hangzhou, 310007, China
Nanjing Drum Tower Hospital

Jiangse, 210008, China
Ningbo First Hospital

Ningbo, 315000, China
Renji Hospital Shanghai Jaotong University School of Medicine

Shanghai, 200120, China
Shanghai General Hospital

Shanghai, 200080, China
The Affiliated Hospital of Inner Mongolia Medical University

Hohhot, 010000, China
The First People's Hospital of Kunshan

Jiangse, 215300, China
The Second Affiliated Hospital of Soochow University

Suzhou, 215004, China
Wuxi People's Hospital

Jiangse, 214023, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.